Harrow, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross
Harrow, Inc. (HROW) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross of 750 shares for the 9-month period ending 2020-09-30, per its 10-Q filed 2020-11-09.
Discontinued › Shareholders' Equity › Shares Granted or Issued, Share-Based Payment Arrangement › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross · last filed 2020-11-09
- Harrow, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2020-09-30 was 0.00 shares.
- Harrow, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2012-12-31 was -4.04M shares.
- Harrow, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2012-09-30 was 85.62K shares.
- Harrow, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2012 was 1.02M shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month |
|---|---|---|---|---|
| 2020-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | 750.00 shares 10-Q · filed 2020-11-09 | ||
| 2020-06-30 | 750.00 shares 10-Q · filed 2020-08-10 | |||
| 2015-09-30 | 130.46K shares 10-Q · filed 2015-11-12 | |||
| 2012-12-31 | -4.04M shares derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18 | -3.96M shares derived: sum of 2 quarters · filed 2013-03-18 | 1.02M shares 10-K · filed 2013-03-18 | |
| 2012-09-30 | 85.62K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-14 | 5.06M shares 10-Q · filed 2012-11-14 | ||
| 2012-06-30 | 4.97M shares 10-Q · filed 2012-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| OPKO HEALTH, INC. (OPK) | United States | $1.220B | -15.59 |
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B | |
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Tyra Biosciences, Inc. (TYRA) | United States | $1.337B | -12.83 |
| Kardigan, Inc. (KARD) | United States | $1.346B |